A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial.

Baran, David A

A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. [electronic resource] - Circulation. Heart failure Mar 2011 - 129-37 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1941-3297

10.1161/CIRCHEARTFAILURE.110.958520 doi


Adrenal Cortex Hormones--therapeutic use
Adult
Aged
Biopsy
Coronary Angiography
Coronary Artery Disease--immunology
Drug Therapy, Combination
Female
Graft Rejection--immunology
Graft Survival--drug effects
Heart Transplantation--adverse effects
Humans
Immunosuppressive Agents--therapeutic use
Kaplan-Meier Estimate
Male
Middle Aged
Mycophenolic Acid--analogs & derivatives
Prospective Studies
Tacrolimus--therapeutic use
Time Factors
Treatment Outcome
Ultrasonography, Interventional
United States